Action ANIP ANI PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues ANI Pharmaceuticals, Inc.

Actions

ANIP

US00182C1036

Temps réel estimé Cboe BZX
Autres places de cotation
 16:17:09 15/05/2024 		Varia. 5j. Varia. 1 janv.
66,18 USD +0,23 % Graphique intraday de ANI Pharmaceuticals, Inc. +0,66 % +19,79 %
10/05 ANI Pharmaceuticals à la recherche d'une fusion-acquisition CI
10/05 ANI Pharmaceuticals, Inc. réitère ses prévisions de résultats pour l'ensemble de l'année 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
ANI PHARMACEUTICALS REPORTS RECORD FIRST QUARTER 2024 FINANCIAL RESULTS AND REITERATES 2024 GUIDANCE
ANI Pharmaceuticals Seeks M&A
ANI Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Full Year 2024
ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Reaffirms Full Year 2024 Earnings, Revenue Guidance
Futures Rebound Pre-Bell Ahead of Earnings, Next Week's Inflation Reports; Asia, Europe Gain
ANI Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
(ANIP) ANI PHARMACEUTICALS Forecasts Fiscal Year 2024 Revenue Range $520M - $542M
(ANIP) ANI PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $4.26 - $4.67
Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q1 Revenue $137.4M, vs. Street Est of $126M
Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q1 EPS $1.21, vs. Street Est of $1.00
ANI: Q1 Earnings Snapshot
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
Ani Pharmaceuticals Insider Sold Shares Worth $1,332,400, According to a Recent SEC Filing
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing
ANI Pharmaceuticals : Corporate Presentation - April 2024
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ANIP
  4. Actualités ANI Pharmaceuticals, Inc.
  5. Autres langues